Abstract
Purpose
Apathy is associated with motor symptoms in Parkinson’s disease (PD); therefore, its evaluation could be influenced by motor disability. The Dimensional Apathy Scale (DAS) evaluates apathy excluding confounding effects of motor symptoms. The present study had three major aims: (a) to explore the psychometric properties of the DAS in non-demented PD patients; (b) to determine an optimal cut-off score of the DAS to identify apathetic PD patients; and (c) to determine a specific apathy profile in PD patients as compared to healthy controls (HC).
Methods
One hundred and seven PD patients and 100 HC completed the DAS. To explore convergent and divergent validity of the DAS in PD, patients underwent the Apathy Evaluation Scale and tools for assessing depressive symptoms, anxiety and cognition. Clinical aspects were recorded. Receiver operating characteristic curve analyses were carried out to estimate the optimal cut-off score to identify clinically significant apathy.
Results
The DAS scores showed high internal consistency and good evidence for convergent and discriminant validity. Maximum discrimination between apathetic and non-apathetic patients was obtained with a cut-off score of 28.5 (total score range: 0–72 with higher score indicating more severe apathy). Comparison between PD and HC groups revealed significant differences on total DAS, behavioural/cognitive initiation and emotional subscales.
Conclusions
The DAS is a valid and reliable tool to assess multidimensional apathy in PD, independently of severity of motor symptoms. Reduced initiation of thought and behaviour and emotional blunting characterised PD patients, without confounding effects of motor disability.
References
Santangelo, G., Trojano, L., Barone, P., Errico, D., Grossi, D., & Vitale, C. (2013). Apathy in Parkinson’s disease: Diagnosis, neuropsychological correlates, pathophysiology and treatment. Behavioral Neurology, 27(4), 501–513.
Robert, P., Onyike, C. U., Leentjens, A. F., Dujardin, K., Aalten, P., Starkstein, S., et al. (2009). Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders. European Psychiatry, 24, 98–104.
Robert, P. H., Clairet, S., Benoit, M., Koutaich, J., Bertogliati, C., Tible, O., et al. (2002). The apathy inventory: Assessment of apathy and awareness in Alzheimer’s disease, Parkinson’s disease and mild cognitive impairment. International Journal of Geriatric Psychiatry, 17(12), 1099–1105.
Sockeel, P., Dujardin, K., Devos, D., Denève, C., Destée, A., & Defebvre, L. (2006). The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: Validation in Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 77(5), 579–584.
Marin, R. S., Biedrzycki, R. C., & Firinciogullari, S. (1991). Reliability and validity of the apathy evaluation scale. Psychiatry Research, 38, 143–162.
Santangelo, G., Barone, P., Cuoco, S., Raimo, S., Pezzella, D., Picillo, M., et al. (2014). Apathy in untreated, de novo patients with Parkinson’s disease: Validation study of apathy evaluation scale. Journal of Neurology, 261(12), 2319–2328. (Erratum in: J Neurol. 2014;261(12):2329. Franco, Santangelo [corrected to Santangelo, Franco]).
Radakovic, R., & Abrahams, S. (2014). Developing a new apathy measurement scale: Dimensional apathy scale. Psychiatry Research, 219, 658–663.
Radakovic, R., Stephenson, L., Colville, S., Swingler, R., Chandran, S., & Abrahams, S. (2016). Multidimensional apathy in ALS: Validation of the dimensional apathy scale. Journal of Neurology, Neurosurgery and Psychiatry, 87, 663–669.
Santangelo, G., Siciliano, M., Trojano, L., Femiano, C., Monsurrò, M., Tedeschi, G., Trojsi, F. (2017). Apathy in Amyotrophic Lateral Sclerosis: insights from Dimensional Apathy Scale. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. doi:10.1080/21678421.2017.1313865
Gelb, D. J., Oliver, E., & Gilman, S. (1999). Diagnostic criteria for Parkinson disease. Archives of Neurology, 56, 33–39.
Dubois, B., Burn, D., Goetz, C., et al. (2007). Diagnostic procedures for Parkinson’s disease dementia: Recommendations from the movement disorder society task force. Movement Disorder, 22, 2314–2324.
Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010). Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Movement Disorder, 25, 2649–2653.
Fahn, S., Elton, R. L., & Members of the UPDRS development committee. (1987). The unified Parkinson’s disease rating scale. In S. Fahn, C. D. Marsden, D. Calne, & M. Goldstein (Eds.), Recent developments in Parkinson’s disease (pp. 153–304). Florham Park, NY: Macmillan Healthcare Information.
Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression, and mortality. Neurology, 17, 427–442.
Psychiatric, American. (2013). Association diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
Santangelo, G., Raimo, S., Siciliano, M., D’Iorio, A., Piscopo, F., Cuoco, S., et al. (2016). Assessment of apathy independent of physical disability: Validation of the Dimensional Apathy Scale in Italian healthy sample. Neurological Sciences, 38(2), 303–309. doi:10.1007/s10072-016-2766-8.
Santangelo, G., Falco, F., D’Iorio, A., Cuoco, S., Raimo, S., Amboni, M., et al. (2016). Anxiety in early Parkinson’s disease: Validation of the Italian observer-rated version of the Parkinson anxiety scale (OR-PAS). Journal of the Neurological Sciences, 367, 158–161.
Isella, V., Mapelli, C., Morielli, N., De Gaspari, D., Siri, C., Pezzoli, G., et al. (2013). Validity and metric of MiniMental Parkinson and MiniMental state examination in Parkinson’s disease. Neurological Sciences, 34(10), 1751–1758.
McHorney, C. A., & Tarlov, A. R. (1995). Individual-patient monitoring in clinical practice: Are available health status surveys adequate? Quality of Life Research, 4, 293–307.
Gravetter, F., & Wallnau, L. (2014). Essentials of statistics for the behavioral sciences (8th ed.). Belmont, CA: Wadsworth.
Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.
Nunnally, J. C. (1978). Psychometric theory (2d ed.). New York: McGraw-Hill.
Ware, J. E., & Gandek, B. (1998). Methods for testing data quality, scaling assumptions, and reliability: The IQOLA project approach. Inter- national quality of life assessment. Journal of Clinical Epidemiology, 51, 945–952.
Youden, W. J. (1950). An index for rating diagnostic tests. Cancer, 3, 32–35.
Christov-Moore, L., Simpson, E. A., Coudé, G., Grigaityte, K., Iacoboni, M., & Ferrari, P. F. (2014). Empathy: Gender effects in brain and behavior. Neuroscience and Biobehavioral Reviews, 46(Pt 4), 604–627. doi:10.1016/j.neubiorev.2014.09.001.
Dujardin, K., Sockeel, P., Devos, D., Delliaux, M., Krystkowiak, P., Destée, A., et al. (2007). Characteristics of apathy in Parkinson’s disease. Movement Disorders, 22, 778–784.
Haber, S. N., & Knutson, B. (2010). The reward circuit: Linking primate anatomy and human imaging. Neuropsychopharmacology, 35(1), 4–26.
Schultz, W. (2007). Behavioral dopamine signals. Trends in Neuroscience, 30, 203–210.
Martínez-Horta, S., Riba, J., de Bobadilla, R. F., Pagonabarraga, J., Pascual-Sedano, B., Antonijoan, R. M., et al. (2014). Apathy in Parkinson’s disease: Neurophysiological evidence of impaired incentive processing. Journal of Neurosciences, 34(17), 5918–5926.
Muhammed, K., Manohar, S., Yehuda, M. B., Chong, T. T., Tofaris, G., Lennox, G., et al. (2016). Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson’s disease. Brain, 139(Pt 10), 2706–2721.
Amanzio, M., Torta, D. M., Sacco, K., Cauda, F., D’Agata, F., Duca, S., et al. (2011). Unawareness of deficits in Alzheimer’s disease: Role of the cingulate cortex. Brain, 134(Pt 4), 1061–1076.
den Brok, M. G., van Dalen, J. W., van Gool, W. A., Moll van Charante, E. P., de Bie, R. M., & Richard, E. (2015). Apathy in Parkinson’s disease: A systematic review and meta-analysis. Movement Disorders, 30, 759–769.
Santangelo, G., Vitale, C., Picillo, M., Moccia, M., Cuoco, S., Longo, K., et al. (2015). Mild cognitive impairment in newly diagnosed Parkinson’s disease: A longitudinal prospective study. Parkinsonism and Related Disorders, 21, 1219–1226.
Kirsch-Darrow, L., Marsiske, M., Okun, M.S., Bauer, R., Bowers, D. (2011). Apathy and depression: separate factors in Parkinson's disease. Journal of the International Neuropsychological Society, 17(6), 1058–1066
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Ethical approval
“All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.”
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Santangelo, G., D’Iorio, A., Piscopo, F. et al. Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale. Qual Life Res 26, 2533–2540 (2017). https://doi.org/10.1007/s11136-017-1569-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-017-1569-6